Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.46 Analyst target: $5.00 Upside: 242.47%
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah.
See the full interactive analysis & chart →Informational only — not investment advice.